vimarsana.com
Home
Live Updates
MOB-015 is recommended for approval in EU: Moberg Pharma : v
MOB-015 is recommended for approval in EU: Moberg Pharma : v
MOB-015 is recommended for approval in EU: Moberg Pharma
/PRNewswire/ -- Moberg Pharma AB (OMX: MOB) hereby announces that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended...
Related Keywords
Netherlands ,
Canada ,
Belgium ,
United States ,
Finland ,
Spain ,
Czech Republic ,
Ireland ,
Stockholm ,
Sweden ,
Hungary ,
Italy ,
Austria ,
Norway ,
Denmark ,
France ,
Swedish ,
American ,
Anna Ljung ,
Moberg Pharma ,
Prnewswire Moberg Pharma ,
Karen Hackney ,
European Union ,
Bayer Consumer Health Head ,
Neither The Company ,
Decentralized Procedure ,
North American ,
Small Cap ,
Nasdaq Stockholm ,